Triheptanoin: long-term effects in the very long-chain acyl-CoA dehydrogenase-deficient mouse
A rather new approach in the treatment of long-chain fatty acid oxidation disorders is represented by triheptanoin, a triglyceride with three medium-odd-chain heptanoic acids (C7), due to its anaplerotic potential. We here investigate the effects of a 1-year triheptanoin-based diet on the clinical p...
Auteurs principaux: | , , , , |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Elsevier
2017-01-01
|
Collection: | Journal of Lipid Research |
Sujets: | |
Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S0022227520314474 |